ArticleExperimental & molecular medicine2018

An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations.

Junyeong Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.